Health

The department began giving away tests Saturday at a series of community events that have seen high demand and people waiting in long lines to get the kits.

The Food and Drug Administration authorization comes one day after the agency cleared a competing drug from Pfizer.

To block a variant this transmissible, scientists say you need an N95 and other high-filtration masks. Here's how to find a good one and when to wear it.

The drug, Paxlovid, is a faster, cheaper way to treat early COVID-19 infections, though initial supplies will be extremely limited.

Vaccines still do a solid job at warding off hospitalization from omicron. Scientists explain how boosters help and the best timing to get one.

An informal survey of the region’s health systems indicates this newest wave of virus cases hasn’t knocked them off their feet — at least not yet.

The Philadelphia Health Department says it’s continuing to place orders for more rapid at-home testing kits, but supply is constrained nationwide.

“Our ability to continue to provide care is without a doubt threatened as the volumes threaten to increase” after the holidays. “This is a balancing act every single day.”

A staffing shortage has left people with intellectual and developmental disabilities without essential services and their families without desperately needed help.

Covid infections are rising and the highly contagious Omicron variant is spreading. Should we change our holiday plans or can we be celebrating together?

Understaffed hospitals are already coping with increased patient demand heading into the holidays. They have few options to expand if omicron creates a huge new wave of COVID.

The Centers for Disease Control and Prevention numbers showed nearly a six-fold increase in omicron's share of infections in only one week.

In the state’s final coronavirus briefing of 2021, Gov. Phil Murphy said New Jersey is seeing daily case counts hitting levels not seen since mid-January of this year.

Sporting events and live theater announced cancellations amid major increases in new coronavirus cases, in large part because of the omicron variant.

Moderna said its current FDA-approved 50-microgram booster shot increased antibody levels against omicron 37-fold compared to pre-booster levels.